Editor's note: With the rapid development of medical technology, precision cancer treatment has become the key to improving the survival rate and quality of life of patients. From July 25 to 28, 2024, the first Frontier Forum on Precision Cancer Therapy was held in Hohhot. The forum brought together many academicians of the Chinese Academy of Sciences and the Chinese Academy of Sciences, national outstanding young people, well-known cancer research scholars and clinical experts, who discussed the frontier topics of tumor precision therapy in depth in the form of keynote speeches, shared the latest research results and clinical experience, and injected new vitality and wisdom into the cause of tumor precision therapy.
Grand opening
This forum invited academicians of the Chinese Academy of Sciences and the Chinese Academy of Sciences, national outstanding young people, famous cancer research scholars and clinical experts to make keynote speeches, conduct in-depth discussions and exchanges on topics, jointly contribute to scientific and technological innovation between regions, create a new platform for scientific research management exchanges, talk about the infinite possibilities brought by precision treatment, and create a high-level scientific and technological innovation and transformation platform. Use the power of science and technology to challenge the disease, protect the happiness and tranquility of every family, contribute wisdom and strength to the cause of tumor precision treatment, and jointly write a brilliant chapter of life!
On the morning of July 27, 2024, Professor Zhang Xiaotian, Vice President of Peking University Cancer Hospital and Executive Director of Inner Mongolia Hospital of Peking University Cancer Hospital, presided over the opening ceremony, and gave a grand introduction to the experts and scholars attending the conference.
Opening remarks
Lu Haiwen, member of the Party Committee and Vice President of Inner Mongolia Medical University, Liu Yong, Secretary of the Party Group and Director of the Health Commission of Inner Mongolia Autonomous Region, and Zhan Qimin, Academician of the Chinese Academy of Engineering, delivered opening speeches.
Lu Haiwen pointed out that with the full implementation of the Healthy China strategy, the people's demand for health is growing, and the key to promoting the high-quality development of the medical and health system has become to build a precision diagnosis and treatment guarantee system for major diseases, accelerate standardized precision treatment and discipline development. Inner Mongolia Autonomous Region is located in northern China, is the birthplace of Mongolia culture, but due to the influence of natural environment and living habits, the incidence of tumor diseases in the region is high, and the task of tumor diagnosis and treatment is arduous. At present, organizations such as the Inner Mongolia Cancer Prevention and Treatment Association and the Autonomous Region Oncology Specialty Alliance have been established in the whole region. He expressed the hope that all experts can take this forum as an opportunity to continue to care for and support the construction and development of higher medical education and medical and health undertakings in Inner Mongolia Autonomous Region. In the development of cancer prevention and treatment in Inner Mongolia Autonomous Region, we will provide more help and guidance, and jointly show new responsibilities and contribute new strength to the construction of a healthy China.
Liu Yong mentioned that the Inner Mongolia Autonomous Region is vast and sparsely populated and rich in natural resources, but the allocation and utilization efficiency of medical resources are low, which is difficult to meet the growing medical needs of the people. At present, the outward transfer rate of patients in Inner Mongolia Autonomous Region is 14.2%, which ranks third in the country. He also mentioned that due to the dietary habits of residents and other reasons, the autonomous region has become an area with a high incidence Mongolia of tumor diseases, and tumor treatment is a shortcoming in the medical system of the autonomous region. He hoped that medical colleagues in the Inner Mongolia Autonomous Region could take this forum as an opportunity to seriously exchange new achievements and new technologies in cancer treatment, learn from their counterparts across the country, and strive to improve the level of cancer prevention and treatment in the autonomous region.
Academician Zhan Qimin pointed out that the Healthy China Strategy has depicted a grand blueprint for cancer prevention and treatment for us, but also put forward arduous tasks. At present, the prevention and treatment of major diseases, especially malignant tumors, is still a long-term and serious health threat. He emphasized the supporting and leading role of scientific and technological innovation in the cause of cancer prevention and treatment. He said that the convening of this conference aims to improve the overall level of tumor research and prevention in the mainland, and also hopes to promote the development of cancer prevention and treatment in Inner Mongolia, and hopes that this conference can continue to be held and become a driving force to promote the hot and difficult point of tumor precision treatment, thereby driving the development of the national tumor cause.
The Frontier Forum was wonderful
This year's Frontier Forum on Tumor Precision Therapy was held in the form of "sharing + discussion", and the whole content was full of dry goods, industry leaders selflessly shared, spoke freely, and knowledge and ideas collided fiercely, jointly creating a high-level academic event!
Under the chairmanship of Professor Liu Zhihua from the Cancer Hospital of the Chinese Academy of Medical Sciences, Academician Zhan Qimin gave a keynote report on "Genetic Variation and Molecular Characteristics of Esophageal Squamous Cell Carcinoma". Professor Zhou Guangbiao from the Cancer Hospital of the Chinese Academy of Medical Sciences, Professor Zhang Huafeng from the University of Science and Technology of China, Professor Lei Haixin from the Institute of Cancer Stem Cells of Dalian Medical University, and Professor Cheng Shuqun from the Oriental Hepatobiliary Surgery Hospital of the Naval Medical University had a heated discussion on this topic.
Under the chairmanship of Professor Xie Keping of the School of Medicine of South China University of Technology, Professor Gao Ping of Southern Medical University/Guangdong Provincial People's Hospital, Professor Wang Hongyan of Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, Professor Zhou Zhaocai of Zhongshan Hospital Affiliated to Fudan University, and Professor Nie Yongzhan of Xijing Hospital of Fudan University and Air Force Military Medical University actively asked questions and had a heated discussion on this topic.
Subsequently, under the chairmanship of Professor Xie Dan of the Cancer Center of Sun Yat-sen University, Academician Dong Erdan of Peking University expressed his personal experience and insights on "On the Innovation and Development of Medical Science and Technology", and Professor He Weiling of Xiang'an Hospital Affiliated to Xiamen University, Professor Hu Zeping of Tsinghua University, and Professor Zhao Hong of Cancer Hospital of Chinese Academy of Medical Sciences discussed this topic on the spot.
Professor Ji Jiafu of Peking University Cancer Hospital gave a report under the chairmanship of Professor Ye Qinong of the Institute of Military Medicine, Academy of Military Sciences, and shared "Gastric Cancer Surgery in the Era of Personalization and Intelligence". The on-site panelists were Professor Wei Bin from the Institute of Translational Brain Science of Fudan University, Professor Ren He from the Medical Department of Qingdao University, and Professor Wang Guihua from Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology.
Professor Yu Xianjun from Fudan University Cancer Hospital gave a lecture entitled "Pancreatic Tumor Surgery: Embracing Precision, Towards Excellence", introducing the new concepts, new ideas and new progress of pancreatic tumor surgery, and the guest was Professor Qin Wenxin from Shanghai Cancer Institute. Professor Xing Jinliang of the Air Force Military Medical University, Professor Chen Jinfei of the First Affiliated Hospital of Wenzhou Medical University, and Professor Wei Jia of the Drum Tower Hospital of Nanjing University School of Medicine had on-site discussions after the report.
Under the chairmanship of Professor Li Jianming of the First Affiliated Hospital of Nanchang University, Academician Teng Gaojun of Zhongda Hospital Affiliated to Southeast University introduced the "Current Situation of Interventional Therapy for Liver Cancer" and shared the relevant explorations and some achievements of the team with colleagues present. Professor Chen Lei from the Oriental Hepatobiliary Surgery Hospital of the Naval Medical University, Professor Wang Hongxia from the Affiliated Cancer Hospital of Fudan University, and Professor Zhang Xiaotian from the Inner Mongolia Hospital of Peking University Cancer Hospital/Peking University Cancer Hospital conducted in-depth discussions on the report.
Under the chairmanship of Professor Huang Canhua of West China School of Basic Medicine and Forensic Medicine, Sichuan University, Academician Yu Jinming of Shandong Cancer Hospital gave a wonderful report on "New Practice of Precision Oncology". Professor Sun Ying from the Cancer Center of Sun Yat-sen University, Professor Peng Zhi from Peking University Cancer Hospital, and Professor Xu Chuan from the Affiliated Hospital of the University of Electronic Science and Technology of China/Sichuan Provincial People's Hospital had a heated discussion at the scene.
Under the chairmanship of Professor Zhang Zhiqian from Peking University Cancer Hospital, Professor Shen Lin from Peking University Cancer Hospital delivered a keynote report on "Exploration and Breakthrough of Precision Treatment of Upper Gastrointestinal Cancer", introducing the breakthrough ideas and development prospects of precision treatment of upper gastrointestinal cancer. Professor Dong Chao from the First Affiliated Hospital of Kunming Medical University, Professor Zheng Jian from the Cancer Center of Sun Yat-sen University, and Professor Pei Jinxin from the Cancer Center of Sun Yat-sen University expressed their views as panelists.
Professor Zheng Limin of Sun Yat-sen University Cancer Center presided over the report under the chairmanship of Professor Cui Rutao of Zhejiang University School of Medicine, with the theme of "Myeloid Cell Source and Tumor Tissue Immune Microenvironment".
Under the chairmanship of Professor Zhang Zhiren of Harbin Medical University, Professor Kang Tiebang of the Cancer Center of Sun Yat-sen University gave a report on "Intercellular Communication and Tumors", and Professor Liu Zhe of the School of Basic Medical Sciences of Hangzhou Normal University, Professor Gao Shan of Southeast University, and Professor Zhu Liqing of Peking University Cancer Hospital discussed the report on the spot.
Concentrate on "precise" forward
At the end of the forum, Professor Shen Lin from Peking University Cancer Hospital made a wonderful summary of the meeting. Professor Shen Lin expressed her gratitude to the participating experts for their strong support to the conference in their busy schedules.
She said that this conference provides a platform for scholars to have in-depth exchanges and learning, and hopes that all colleagues can face to face, form "small vesicles", go deep into tumor tissues and cells, and understand the substantive connotation and in-depth significance. At the same time, he said that as a new starting point, this forum has made countless sparks collide with ideas in the northern Xinjiang of the motherland, and I believe that there will be new breakthroughs in tumor research in the future, and there will be new development in the medical industry!
So far, the "First Frontier Forum on Tumor Precision Therapy" and the National Cancer Early Diagnosis and Treatment Training Course· and the Working Conference of the National Heavy Laboratory Achievement Transformation Base have come to a successful conclusion! This activity has played a positive role in deepening the implementation of the national strategic deployment, promoting academic exchanges and cooperation, strengthening the ability of early diagnosis and treatment of cancer, and promoting the transformation and application of achievements.
Although the event has come to an end, the spirit and significance of this event are far from over. I believe that through this activity, every participant has gained something and thought about it, which will inspire everyone to continue to move forward on the road of precision cancer treatment. We look forward to more scientists, doctors and researchers joining this great cause in the future to explore new boundaries of cancer treatment.
Peking University Cancer Hospital Inner Mongolia Hospital will continue to uphold its original intention, continuously promote scientific and technological innovation and transformation of achievements, bring more hope and light to cancer patients, and let patients enjoy high-quality life.
Finally, thank you to everyone involved for their contributions and support, you are the ones who made this possible. Let us join hands to meet a more brilliant tomorrow!
Academician demeanor
A glimpse of the session
Copyright Notice
The copyright of this article belongs to the "Publicity Department of Inner Mongolia Hospital, Peking University Cancer Hospital".